Research, Select, & Monitor Wednesday, February 19, 2020 5:04:08 AM ET  
Trade Ideas The Market Industries Stocks Portfolio

Ticker Lookup
Endo International plc$5.95($.20)(3.25%)

  Quote | Ranking | Chart | Valuations | Sentiment | News | Earnings | Analysts | More...

Your Target?

  Endo International plc vs Drug Delivery

Endo International plc is a global specialty healthcare company. It develops, manufactures, markets, and distributes quality branded pharmaceutical and generic products as well as medical devices. Endo offers branded prescription products, including Lidoderm, Opana ER, Percocet, Voltaren Gel, Frova, Supprelin LA, Vantas, Valstar and Fortesta Gel for pain, urology, endocrinology, and oncology. The company also provides non-branded generic products in the pain management, urology, central nervous system disorders, immunosuppression, oncology, women's health, and hypertension markets. Endo International plc, formerly known as Endo Pharmaceuticals Holdings Inc., is headquartered in Dublin, Ireland.

Innovative companies whose purpose is to design and develop new ways to introduce drugs to the body. These new methods may consist of time-released capsules, differing injection techniques, or enabling certain drugs to be taken orally that may not have been to be taken so before. Their revenue is obtained from selling their technology to pharmaceutical companies or licensing it to manufacturers of prescription drugs.
 Totals Company Industry
  Sales: N/A $115,493.6 Mil
  Market Cap: $1,349.3 Mil $477,590.7 Mil
  Analysts Recommendation: Hold Buy

 Averages Company Industry
  Historic Revenue: N/A 4.3%
  Estimated Revenue: N/A 6.5%
  Historic Earnings: N/A 24.2%
  Estimated Earnings: N/A 20.5%
  Stock Price (1 Year): (43.7%) (12.2%)
  Cash per Share: N/A (3.7%)
  Dividend: N/A N/A
  Trailing PE: N/A N/A
  Forward PE: 2.6 29.6
  Price-to-Sales: N/A N/A
  Price-to-Book: N/A 4.1
  Dividend Yield: N/A N/A
  Market Cap: $1,349.3 Mil $36,737.7 Mil
  Net Margin: N/A 7.5%
  Gross Margin: N/A 69.9%
  Return on Equity: N/A .1
  Return on Assets: N/A .0
  Balance Sheet
  Current Ratio: N/A 1.8
  Quick Ratio: N/A 1.3
  Cash Ratio: N/A .7
  Debt-to-Equity: N/A .8
  Interest Coverage: N/A (.5)
  Relative-Strength Index: 56.0 N/A

 Other companies in Drug Delivery Price Market Cap
  Roche Holding AG  (RHHBY) $44.10 $301,984.2 Mil
  Sanofi  (SNY) $51.14 $128,061.7 Mil
  Eisai Co Ltd  (ESALY) $80.11 $22,951.7 Mil
  Dr. Reddys Laboratories Ltd.  (RDY) $45.26 $7,543.3 Mil
  Amarin Corporation plc  (AMRN) $18.19 $6,497.6 Mil

Register |  Password |  Feedback |  Copyright |  Usage Agreement |  Privacy Policy |  Advertising |  About Us |  Contact Us |  FAQ 

Past performance is not indicative of future results, the logo, and News Selects are trademarks of
Copyright © 1998 - 2020 All rights reserved.